Tiziana Life Sciences Ltd.

Contributing Author

Recent Articles by Tiziana Life Sciences Ltd.

Sep-30	Tiziana Life Sciences Invited to Attend Life Sciences Innovation Forum 2025 in Riyadh, Saudi Arabia TLSA GlobeNewswire
Sep-25	Tiziana to Advance TZLS-501 - Its Fully Human IL-6R Monoclonal Antibody TLSA GlobeNewswire
Sep-24	Tiziana Life Sciences Announces Poster Presentation on Intranasal Foralumab Clinical Trial at the 41st ECTRIMS Congress TLSA GlobeNewswire
Sep-15	Department of Defense Awards Grant to Advance Tiziana Life Sciences Intranasal Anti-CD3 Therapy for Spinal Cord Injury TLSA GlobeNewswire
Sep-09	Tiziana Life Sciences Announces Purchase of Shares by Chief Executive Officer TLSA GlobeNewswire
Sep-09	Tiziana Life Sciences Announces Purchase of Shares by Chief Executive Officer TLSA GlobeNewswire
Sep-05	Tiziana Life Sciences Announces Purchase of Shares by Chairman TLSA GlobeNewswire
Aug-14	Tiziana Life Sciences Doses First Patient in Phase 2a Trial of Intranasal Foralumab for Multiple System Atrophy TLSA GlobeNewswire
Aug-11	FDA Approves Tiziana Life Sciences Phase 2 IND for Multiple System Atrophy TLSA GlobeNewswire
Jul-21	Tiziana Life Sciences Announces Immunologic Analysis of Nasal Foralumab in Moderate Alzheimer's Patient TLSA GlobeNewswire
Jun-13	Tiziana Life Sciences Expands Phase 2 Clinical Trial of Intranasal Foralumab with Commencement of First Patient Dosing at Weill Cornell Multiple Sclerosis Center TLSA GlobeNewswire
Jun-13	Tiziana Life Sciences to Present at the Bio International Convention TLSA GlobeNewswire
May-23	Tiziana Life Sciences Announces Interview Highlighting Intranasal Foralumab for the Treatment of Moderate Alzheimer's Disease TLSA GlobeNewswire
May-15	Journal of Clinical Nuclear Medicine Publishes Results of Tiziana's Nasal Foralumab in Study Treating Moderate Alzheimer's Disease TLSA GlobeNewswire
May-12	Tiziana Life Sciences Announces Purchase of Shares by Chairman TLSA GlobeNewswire
May-09	Tiziana Life Sciences Announces Significant Reduction in Microglia Activation in PET Scan of Moderate Alzheimer's Patient Treated with Intranasal Foralumab TLSA GlobeNewswire
May-06	Tiziana Life Sciences Announces Comprehensive Positive Results from Study of Nasal Foralumab in Patients with Multiple Sclerosis TLSA GlobeNewswire

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2025 Finviz.com. All Rights Reserved.